Larvol Delta - Early-response-to-ivarmacitinib-and-its-impact-on-longterm-efficacy-in-patients-with-moderatetosevere-atopic-dermatitis-a-post-hoc-analysis-of-a-phaseIII-trial

AiSuDa (ivarmacitinib) - Jiangsu Hengrui Pharma, Arcutis

http://www.ncbi.nlm.nih.gov/pubmed/42454646

Feng Hu; Jinbo Chen; Liuqing Chen; Ping Zhang

Jul 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next